Thailand to Expand the Use of Medical Cannabis for Treating Pediatric Epilepsy

It is understood that Thailand is about to implement a crucial policy change in its healthcare system, primarily targeting pediatric patients with refractory epilepsy. Meanwhile, this coincides with a significant milestone in the revision of Thailand’s new cannabis law, sparking strong industry interest.

Some analysts believe that this measure represents the Thai government’s potential attitude towards cannabis and the direction of policy adjustment. In summary, there are the following three points:

  • Importance: The National Health Security Office (NHSO) of Thailand is adjusting its policies to allow for the “genuine use” of medical cannabis oil in treating pediatric epilepsy, marking a significant shift towards patient-centered care.
  • Global Impact: This decision reflects Thailand’s inclusion of cannabis in medical treatment following successful clinical trials and increasing evidence of its efficacy in refractory epilepsy cases, further highlighting the prominence of medical cannabis.
  • Key Point: Regulatory changes signify broader acceptance of medical cannabis within Thailand’s healthcare system and underscore the country’s commitment to evidence-based medical practices and improving patient treatment outcomes.

According to reports from Bangkok, Thailand is set to implement a significant policy change in its healthcare system, allowing for the allocation of medical cannabis oil to pediatric epilepsy patients based on “actual usage.”

This adjustment by the National Health Security Office (NHSO) of Thailand marks a significant shift in the country’s approach to medical cannabis, emphasizing the prioritization of patient needs and treatment efficacy over strict prescription restrictions.

It is understood that prior to this, the policy of the NHSO only allowed for a maximum of 6 bottles of 10-milliliter medical cannabis oil per patient per month. However, there is now a reconsideration to increase this limit to accommodate the actual needs of patients, reflecting a more flexible and compassionate healthcare practice.

This shift came about between 2021 and 2023 following extensive research and trials led by Dr. APHASIRI LUSAWAT, a pediatric neurologist at the Institute of Neurology under the Ministry of Health Services. These studies focused on the use of cannabis extracts with high CBD content to treat pediatric refractory epilepsy and yielded positive results, ultimately leading to the revision of this policy.

The NHSO, in collaboration with the Ministry of Health Services and the Thai Pediatric Neurological Society, has been at the forefront of these efforts, demonstrating Thailand’s commitment to exploring medical approaches and integrating traditional herbal remedies into modern healthcare practices.

Industry professionals believe that this regulatory change not only aligns with Thailand’s commitment to providing evidence-based healthcare but also sets a precedent for the use of medical cannabis in pediatric care. Recognizing the significant potential of cannabis oil in improving the quality of life for children with severe epilepsy marks a hopeful future for treating similar cases.

As Thailand continues to explore and acknowledge the medical potential of cannabis, this policy adjustment demonstrates the country’s progressive stance in healthcare, aiming to ensure that all patients, especially vulnerable pediatric patients, receive the best medical care tailored to their specific needs.

This news is really fantastic! Thailand’s bold reform of medical cannabis policy is, in my opinion, a very positive and significant development, showcasing the government’s openness and patient-centered care in healthcare policy.

They have begun to recognize and accept the important role of cannabis in treating pediatric refractory epilepsy, no longer rigidly restricting dosage but adjusting the distribution of medical cannabis oil according to the actual needs of the children, which is very compassionate!

Experts in Thailand, after a series of solid research and trials, have found that cannabis extracts high in CBD can effectively help children control seizures. Such research findings directly led to the revision of relevant policies, which is commendable!

Moreover, the collaboration among relevant departments in Thailand to promote this initiative shows their sincere desire to improve medical practices by integrating traditional herbal wisdom with modern healthcare, all to ensure that these children with illnesses receive the most suitable and effective treatment.

With this move, Thailand has taken a significant step forward in the field of medical cannabis, showcasing not only its rigor in evidence-based medicine but also setting a good example for the world – demonstrating that we can use cannabis more openly and scientifically to improve the quality of life for children suffering from epilepsy.

Overall, Thailand’s breakthrough in medical cannabis undoubtedly contributes to the global healthcare industry, signaling a solid step forward for Thailand in the modernization of medical technology and healthcare policy.

Get in touch with us!

From custom light planning, to tailored quotes, and everything in between, our team of horticulture experts are always ready to assist.

Please enable JavaScript in your browser to complete this form.
** Your privacy will be protected

Get Catalogue & Price List​

Please enable JavaScript in your browser to complete this form.
** Your privacy will be protected
Open chat
Inquiry Us
Hello 👋
Are you looking for LED Grow Lights?